Kyla Lara-Breitinger is a Cardiology physician. OpenAlex indexes 49 publications with 485 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 3 Mar 2023.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202517 payments
- Edwards Lifesciences CorporationProgram year20241 payment
- Abbott LaboratoriesProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
53.9%Statin27.6%Rosuvastatin Calcium100%Part D<11 patientsCholesterol absorption inhibitor26.3%Ezetimibe100%Part D<11 patientsMetabolism & gastrointestinal
46.1%GLP-1 receptor agonist46.1%Ozempic51%Mounjaro49%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of incretin therapies on biochemical and imaging outcomes in metabolic dysfunction–associated steatotic liver disease
American Journal of Preventive Cardiology
2026 - Accelerated biological aging in bipolar disorder as determined by artificial intelligence-based electrocardiographic assessment
Journal of Affective Disorders
2026 - 26-A-12981-ACC ARTIFICIAL INTELLIGENCE-ESTIMATED RIGHT VENTRICULAR FUNCTION ADDS SIGNIFICANT PROGNOSTIC VALUE IN TRICUSPID REGURGITATION
Journal of the American College of Cardiology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”